Combination Comprising Everolimus and Amcenestrant

A combination comprising amcenestrant or a pharmaceutically acceptable salt thereof, and everolimus.

A method of treating cancer comprising administering to a patient in need thereof a therapeutically effective amount of amcenestrant or a pharmaceutically acceptable salt thereof, in combination with a therapeutically effective amount of everolimus.

A pharmaceutical composition comprising amcenestrant or a pharmaceutically acceptable salt thereof, everolimus, and at least one pharmaceutically acceptable excipient.

A method of treating cancer in a patient who is being treated with amcenestrant or a pharmaceutically acceptable salt thereof, comprising administering to the patient an effective amount of everolimus.

A method of treating cancer in a patient on stable treatment with amcenestrant or a pharmaceutically acceptable salt thereof, comprising administering to the patient a therapeutically effective amount of everolimus.

A method of treating cancer comprising administering to a patient in need thereof a therapeutically effective amount of everolimus, wherein the patient is also being treated with amcenestrant or a pharmaceutically acceptable salt thereof.

A kit comprising:

• a first pharmaceutical composition comprising amcenestrant or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable excipient;
• a second pharmaceutical composition comprising everolimus and at least one pharmaceutically acceptable excipient;
• wherein the first pharmaceutical composition and the second pharmaceutical composition are in separate compartments.